SCHEMBL4598879

SCHEMBL4598879

O=C(O)N1CCOCC1c1cccc(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.47
TMEM97 Q5BJF2 3/20 0.42
SIGMAR1 Q99720 3/20 0.42
PIK3C3 Q8NEB9 2/20 0.42
NTRK1 P04629 1/20 0.42
NTRK3 Q16288 1/20 0.42
NTRK2 Q16620 1/20 0.42
BACE1 P56817 1/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
SCD5 Q86SK9 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAOB P27338 1/20 0.40
PDE5A O76074 1/20 0.39
PKM P14618 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14829587 0.84 BACE1 (0.53) RIPK1TMEM97SIGMAR1PIK3C3BACE1
SCHEMBL7599925 0.82 CCNC (0.40) TMEM97SIGMAR1BACE1SCD5
SCHEMBL6246105 0.78 RIPK1 (0.66) RIPK1TMEM97SIGMAR1SCD5PDE5A
SCHEMBL4293223 0.77 PIK3C3 (0.45) RIPK1PIK3C3NTRK1NTRK3NTRK2
SCHEMBL27364822 0.75 BACE1 (0.53) RIPK1TMEM97SIGMAR1PIK3C3BACE1
SCHEMBL18783107 0.75 RIPK1 (0.44) RIPK1PIK3C3NTRK1NTRK3NTRK2
SCHEMBL29116156 0.75 RIPK1 (0.49) RIPK1NTRK1SCD5MAOBPDE5A
SCHEMBL14829293 0.74 BACE1 (0.42) RIPK1TMEM97SIGMAR1BACE1SCD5
SCHEMBL14829504 0.74 BACE1 (0.42) RIPK1TMEM97SIGMAR1BACE1SCD5
SCHEMBL29138895 0.74 CCNC (0.45) HDAC1HDAC8HDAC6SCD5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed